Behind the SeizureTM

Expedite diagnosis. Impact care.

Order form

No-cost epilepsy gene panel testing program

Invitae and BioMarin have partnered to offer no-cost Invitae Epilepsy Panel testing for 2–4 year olds that meet the patient eligibility requirements to ensure patients benefit from genetic insights early in their care.

Genetic research is rapidly advancing our understanding of the underlying causes of epilepsy and clinical implications for disease management. In as little as 2 weeks, an epilepsy gene panel test can bring you and your patients closer to identifying the genetic cause behind the seizure. Determining a genetic basis of disease for children with unprovoked seizures has the potential to impact clinical management.

Eligibility

Learn more

Ordering instructions

Learn more

Program eligibility

  • child age at test order: ≥24 months to <60 months
  • unprovoked seizure onset at ≥24 months

Invitae Epilepsy Panel

The Invitae Epilepsy Panel offers a comprehensive analysis for inherited epilepsy, including up to 180+ genes that are associated with both syndromic and non-syndromic causes.

Benefits of genetic testing:

  • Tailor care to a patient’s specific needs
  • Help patients enroll in clinical trials
  • Shorten the time to diagnosis
  • Identify risk of disease for family members
  • Connect families with patient advocacy organizations
VIEW PANEL

Ordering made easy

Place your order Collect a specimen Results

To qualify for the program, please be sure to follow all the steps below.

To place a paper-based order, download the paper order form.

To place an order online:

  1. Sign up or log into your account and start a new order
  2. Fill in the required patient information
  3. Under Reason for testing, select Panel/Gene Test
  4. Search for and select the Invitae Epilepsy Panel in the test catalog and add it to the order; add preliminary-evidence genes if desired
  5. Under Billing information, select institutional billing and in the Purchase order number field enter "Behind the Seizure"; leave the rest of the billing section blank
  6. Fill out, print and sign the program eligibility requirements form and include it with the specimen (alternatively you can upload the form to the portal by selecting yes to family history of disease and including it as an attachment in the Upload pedigree section)

To collect a specimen:

  1. Order a specimen collection kit
  2. Label the sample tube with the patient’s full name, date of birth, and sample collection date
  3. Include the signed program eligibility requirements form with the specimen
  4. For additional information on specimen requirements, please click here

To receive results:

  1. Once Invitae receives the sample, you will receive the results in 10-21 calendar days, 14 days on average
  2. If you created an online account, you can view the status of your order by logging into your account
  3. You will receive a notification email once the test results are ready

Support every step of the way 

Client Services

Available to answer your questions or help you through the testing process.

CONTACT

Clinical Support Services

Licensed, board-certified genetic counselors, ready to support you.

SUPPORT

Confidence begins with quality

  • Commitment to quality: Invitae’s >1000 patient peer-reviewed study, published in the Journal Molecular Diagnostics, the official journal of the Association for Molecular Pathology, shows equivalence to established standards.
  • Quick turnaround: results available within 10–21 calendar days, 14 days on average.
  • Sample options: blood, saliva, and assisted saliva kits (ideal for young children) provided free of charge.
  • Strong team: Invitae has more than 300 experts in genetics, bioinformatics, engineering, technology, and commercial development including board-certified medical geneticists with experience in diagnosing biochemical and molecular causes of epilepsy.

About Invitae

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene tests today.


About BioMarin

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. With more than 2,200 employees in 52 countries, BioMarin is recognized as an industry leader in getting therapies to market quickly and for our ongoing investment in research and development. BioMarin has 6 approved medicines considered to be first-in-class and best-in-class therapies for rare diseases—no patient population is too small. BioMarin is excited to bring their experiences and capabilities to CLN2 disease. Visit www.BioMarin.com to learn more.